Efficacy and Safety of MMFS-01, a Synapse Density Enhancer, for Treating Cognitive Impairment in Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial
Liu G, et al.
Journal of Alzheimer's Disease, 2016
The Magtein-based MMFS-01 formulation improved cognitive outcomes in older adults with cognitive impairment in a 12-week RCT.
Key Finding
MMFS-01, a magnesium L-threonate–based formulation, improved performance across multiple cognitive domains over 12 weeks in older adults with cognitive impairment.